Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EQS-Adhoc: Marinomed Biotech AG: Court opens restructuring proceedings without self-administration

eqs_en 
0 0 14.08.24
EQS-Adhoc: Marinomed Biotech AG: Court opens restructuring proceedings without self-administration
 

EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency/Restructure of Company
Marinomed Biotech AG: Court opens restructuring proceedings without self-administration

14-Aug-2024 / 15:35 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Korneuburg, Austria, 14. August 2024 – Marinomed Biotech AG (VSE:MARI) announces that on August 14, 2024, the Regional Court of Korneuburg opened restructuring proceedings without self-administration at the request of Marinomed Biotech AG. The Company expects trading of Marinomed shares to resume soon and a switch to the standard market continuous on the Vienna Stock Exchange. 

+++ End of ad-hoc announcement +++ 


End of Inside Information

14-Aug-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com
Language: English
Company: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Phone: +43 2262 90300
E-mail: [email protected]
Internet: www.marinomed.com
ISIN: ATMARINOMED6
WKN: A2N9MM
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange (Official Market)
EQS News ID: 1968247

 
End of Announcement EQS News Service

1968247  14-Aug-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1968247&application_name=news&site_id=sharewise~~~202ee175-2c72-4a50-a0f7-89cd8fcfa533

Marinomed Biotech AG Stock

€2.83
197.890%
Marinomed Biotech AG dominated the market today, gaining €1.88 (197.890%).

Show more
Like: 0
Share
eqs_en 
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments

Not a member yet? Sign up for free!